felodipine has been researched along with Stroke in 7 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
Excerpt | Relevance | Reference |
---|---|---|
"In newly diagnosed patients with hypertension, lercanidipine was superior to nifedipine in the six-year period when the analyzed endpoint was stroke." | 7.85 | Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study. ( Cheng, KC; Cheng, KH; Cheng, KY; Lai, WT; Lee, CW; Yang, YH, 2017) |
"In newly diagnosed patients with hypertension, lercanidipine was superior to nifedipine in the six-year period when the analyzed endpoint was stroke." | 3.85 | Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study. ( Cheng, KC; Cheng, KH; Cheng, KY; Lai, WT; Lee, CW; Yang, YH, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, KH | 1 |
Cheng, KC | 1 |
Cheng, KY | 1 |
Yang, YH | 1 |
Lee, CW | 1 |
Lai, WT | 1 |
Zhang, Y | 2 |
Zhang, X | 2 |
Liu, L | 2 |
Zanchetti, A | 2 |
Jönsson, B | 1 |
Hansson, L | 1 |
Stålhammar, NO | 1 |
Liu, G | 1 |
Li, W | 1 |
Modeliard, SS | 1 |
Serot, JM | 1 |
Mansour, J | 1 |
Achard, JM | 1 |
Fournier, A | 1 |
Soucek, M | 1 |
Plachý, M | 1 |
Fischberg, GM | 1 |
Lozano, E | 1 |
Rajamani, K | 1 |
Ameriso, S | 1 |
Fisher, MJ | 1 |
4 trials available for felodipine and Stroke
Article | Year |
---|---|
Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study.
Topics: Age Factors; Aged; Antihypertensive Agents; Asian People; Blood Pressure; Cardiovascular Diseases; C | 2010 |
Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension.
Topics: Aged; Antihypertensive Agents; Aspirin; Blood Pressure; Calcium Channel Blockers; Cost-Benefit Analy | 2003 |
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Ch | 2005 |
[The FEVER (Felodipine EVEnt Reduction) trial; a randomised, double-blind, placebo-controlled trial in Chinese hypertensive patients].
Topics: Aged; Calcium Channel Blockers; China; Diuretics; Double-Blind Method; Felodipine; Female; Humans; H | 2007 |
3 other studies available for felodipine and Stroke
Article | Year |
---|---|
Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study.
Topics: Adolescent; Adult; Aged; Amlodipine; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Dihyd | 2017 |
FEVER study: a trial further supporting the concept of a blood pressure-independent stroke protective effect by dihydropyridines.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Felodipine; Female; Heart Rate; Hum | 2006 |
Stroke precipitated by moderate blood pressure reduction.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Emergency Treatment; Felodipine; Female; Humans; Hyp | 2000 |